Safety profile of docetaxel in older patients with metastatic breast cancer.

被引：0
|
作者：
Aapro, MS
Olsen, SR
Alakl, M
Murawsky, M
Hurria, A
机构：
[1] Clin De Genolier, Genolier, Switzerland
[2] Aventis Pharmaceut, Bridgewater, NJ USA
[3] Aventis Pharmaceut, Antony, France
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
532
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [41] Patterns of treatment outcomes in older patients with metastatic pancreatic cancer.
    Jung, Hyun Ae
    Lim, Sung Hee
    Han, Boram
    Kim, Ho Young
    Kim, Hyo Jung
    Zang, Dae Young
    Jung, Joo Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [42] Adding Xeloda (capecitabine) to docetaxel significantly improves survival and does not compromise quality of life in patients with metastatic breast cancer.
    Twelves, C
    Fumoleau, P
    Jones, SE
    Cherubini, R
    Foimtchuk, MJ
    Kroener, JF
    Martin, M
    Mennel, RG
    Tang, SC
    Van Hazel, GA
    Wigler, N
    Osoba, D
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 307 - 307
  • [43] Weekly docetaxel in patients with metastatic breast cancer: A Bangladeshi perspective.
    Hoque, Ehteshamul
    Karim, Shanaz
    Ahmed, Rakib Uddin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Phase II study of weekly docetaxel in patients with metastatic breast cancer
    Aihara, T
    Kim, Y
    Takatsuka, Y
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 286 - 292
  • [45] Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancer
    Liljegren, Annelie
    Bergh, Jonas
    Castany, Roser
    BREAST, 2009, 18 (04): : 259 - 262
  • [46] Randomized trial comparing docetaxel and paclitaxel in patients with metastatic breast cancer
    Jones, S
    Erban, J
    Overmoyer, B
    Budd, GT
    Hutchins, XL
    Lower, E
    Laufman, L
    Sundaram, S
    Urba, W
    Olsen, S
    Meyers, ML
    Ravdin, PM
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S9 - S9
  • [47] Phase III randomized trials of docetaxel in patients with metastatic breast cancer
    Crown, J
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 33 - 38
  • [48] Immunological profile of metastatic or recurrent breast cancer patients
    Imoto, Shigeru
    Ueno, Takayuki
    Isaka, Hirotsugu
    Ito, Hiroki
    Miyamoto, Kaisuke
    Chiba, Tomohiro
    Kamma, Hiroshi
    CANCER RESEARCH, 2016, 76
  • [49] Nab-paclitaxel utilization pattern and safety profile in patients with metastatic breast and pancreatic cancer
    Cortes de Miguel, S.
    Ruiz Fuentes, S.
    Belda Rustarazo, S.
    Valle Corpas, M.
    Casas Hidalgo, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 507 - 507
  • [50] Optimizing the timing of eribulin monotherapy for patients with metastatic breast cancer.
    Shingaki, Sumito
    Kogawa, Takahiro
    Shimokawa, Mototsugu
    Fujimoto, Yumi
    Harano, Kenichi
    Naito, Yoichi
    Matsubara, Nobuaki
    Matsui, Reiko
    Hosono, Ako
    Mukai, Hirofumi
    Mukohara, Toru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345